Clinical Trial Update: Evaluation of a Venous-Return Assist Device (Venowave) to Treat Post-Thrombotic Syndrome: A Randomized Controlled Trial [Phase 3]

View source ↗

Summary

Phase 3 randomized controlled trial evaluating the Venowave venous-return assist device for post-thrombotic syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-thrombotic Syndrome

Snippet

Sponsor: Hamilton Health Sciences Corporation | Conditions: Postphlebitic Syndrome | Phase 3 | Status: COMPLETED